Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand
10-Mar-2015
North America
Market Research
NE4E-01-00-00-00
LS00049-NA-MR_16890
This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.
Key Findings
Key Findings (continued)
Scope and Segmentation
Market Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Key Companies to Watch (continued)
Executive Summary—2 Big Predictions
Executive Summary—2 Big Predictions (continued)
Executive Summary—2 Big Predictions (continued)
Market Background
Market Background—Types of Blood Bank Analyzers
Market Background—Types of Blood Bank Analyzers (continued)
Market Background—Types of Blood Bank Analyzers (continued)
Comparison of Immunohematology Methods
Voice of Customer—Factors Governing Equipment Purchase for a Transfusion Laboratory
Voice of Customer
Market Segmentation
Procurement Process
Defining Future Healthcare Trends
New Market Opportunities
New Market Opportunities (continued)
Market Drivers
Market Restraints
Market Impact of Top 6 Trends
Market Engineering Measurements
Market Engineering Measurements (continued)
Factors Impacting Market Forecasts
Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening
Medicare Expenditure for Abo, Rh, and RBC Antigen Typing
Test Volume and Pricing Analysis for Blood Grouping Tests
Test Volume and Pricing Analysis for Blood Grouping Tests (continued)
Medicare Expenditure for Antibody Screening, Identification, and Cross Matching
Revenue Forecast
Revenue Forecast for Serological and Molecular
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Test Volume and Pricing Analysis for Disease Screening and NAT Tests
Test Volume Serological Donor Screening Tests
Test Volume Serological Donor Screening Tests (continued)
Cost Comparison per Test for Serological and NAT
Most Frequently Ordered Blood Tests by Rank
Accredited Immunohematology Reference Laboratories
Accredited Immunohematology Reference Laboratories (continued)
Accredited Immunohematology Reference Laboratories (continued)
Accredited Immunohematology Reference Laboratories (continued)
Accredited Immunohematology Reference Laboratories (continued)
Blood Transfusion Centers
Overview of Supply Chain in Blood Banks
Overview of Supply Chain in Blood Banks (continued)
Problem Areas and Solution
Market Share
Market Share Analysis
Product Analysis Blood Grouping
Product Analysis Blood Grouping (continued)
Product Analysis Disease Screening (Serological and Molecular)
Product Analysis Disease Screening (Molecular Assays)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Immucor
Ortho Clinical Diagnostics
Beckman Coulter (Danaher)
BioRad
Quotient Limited (previously known as Alba Bioscience)
Immucor
Diagast
3Ti (Transfusion & Transplantation Technologies)
The Last Word—2 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
Legal Disclaimer
Drivers Explained
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Additional Studies of Interest
Additional Studies of Interest (continued)
Market Engineering Methodology
Learn More—Next Steps
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | NE4E-01-00-00-00 |
| Is Prebook | No |
The US Blood Transfusion Diagnostics Market
$4,950.00
Special Price $3,712.50 save 25 %